NEW YORK (AP) — Ever since college, Brad Jobling struggled with his weight, fluctuating between a low of 155 pounds when he was in his 30s to as high as 220. He spent a decade tracking calories on WeightWatchers, but the pounds he dropped always crept back onto his 5-foot-5-inch frame.
A little over a year ago, the 58-year-old Manhattan resident went on a new weight loss drug called Wegovy. He’s lost 30 pounds, and has started eating healthier food and exercising — the habits behind many commercial diet plans and decades of conventional wisdom on sustainable weight loss.
Yet Jobling’s experience also has altered his perspective on dieting. He now sees obesity as a disease that requires medical intervention, not just behavioral changes. In fact, he thinks he will need to stay on a drug like Wegovy for the rest of his life even though it has taken some of the joy out of eating.
Xi stresses boosting guarantee ability of land element for high
North China's Hebei launches new multimodal transport route to Central Asia
White salt flats become black fertile fields
Ed Sheeran enjoys a rare date night with his wife Cherry Seaborn at Michelin starred restaurant
China Focus: Vibrant festival highlights cultural charm of various Chinese ethnic groups
The main forum of Global Digital Economy Conference 2023 Lhasa Summit was held
North China's Hebei launches new multimodal transport route to Central Asia
Poland lays claim to a leadership role in Europe as Russia's war threatens stability
Domestic brands shine at 4th CICPE in S China's Hainan